Share-based payments (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
|---|
| Share-Based Payment Arrangements [Abstract] |
|
| Summary of Number and Weighted Average Exercise Prices of Share Options |
Set out below are summaries of MIP Grant Options and MIP Performance Options granted under the plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
|
Average exercise price per share option (in €) |
|
Number of MIP Grant Options |
|
Number of MIP performance options |
|
Average exercise price per share option (in €) |
|
Number of MIP Grant Options |
|
Number of MIP Performance Options |
| As at January 1 |
|
0.12 |
|
|
1,329,213 |
|
|
1,329,213 |
|
|
— |
|
|
— |
|
|
— |
|
| Granted during the period |
|
— |
|
|
— |
|
|
— |
|
|
0.12 |
|
|
1,329,213 |
|
|
1,329,213 |
|
| Exercised during the period |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
| Forfeited during the period |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
| As at September 30 |
|
0.12 |
|
|
1,329,213 |
|
|
1,329,213 |
|
|
0.12 |
|
|
1,329,213 |
|
|
1,329,213 |
|
| Vested and exercisable at September 30 |
|
0.12 |
|
|
1,329,213 |
|
|
996,910 |
|
|
— |
|
|
— |
|
|
— |
|
Set out below is a summary of LTIP Performance Options granted under the plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
Average exercise price per LTIP Performance Option (in €) |
|
Number of LTIP Performance Options |
| As at January 1 |
|
— |
|
|
— |
|
| Granted during the period |
|
0.12 |
|
|
3,059,955 |
|
| Exercised during the period |
|
— |
|
|
— |
|
| Forfeited during the period |
|
— |
|
|
— |
|
| As at September 30 |
|
0.12 |
|
|
3,059,955 |
|
| Vested and exercisable at September 30 |
|
— |
|
|
— |
|
|
| Summary of Range of Exercise Prices of Outstanding Share Options |
Share options outstanding at the end of the reporting period have the following expiry dates and exercise prices:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options |
|
Grant date |
|
Expiry date |
|
Exercise price (in €) |
|
Share options
September
30, 2023 |
| MIP Grant Options |
|
May 14, 2022 |
|
September 17, 2033 |
|
0.12 |
|
|
1,329,213 |
|
| MIP Performance Options |
|
May 14, 2022 |
|
May 13, 2032 |
|
0.12 |
|
|
996,910 |
|
| MIP Performance Options (modified) |
|
May 14, 2022 |
|
April 29, 2034 |
|
0.12 |
|
332,303 |
|
| Total |
|
|
|
|
|
|
|
2,658,426
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options |
|
Grant date |
|
Vesting date |
|
Expiry date |
|
Exercise price (in €) |
|
Number of options
September
30, 2023 |
| LTIP Performance Options (2022) |
|
April 12, 2023 |
|
April 12, 2025 |
|
April 12, 2032 |
|
0.12 |
|
|
1,039,222 |
|
| LTIP Performance Options (2023) |
|
January 1, 2023 |
|
April 12, 2026 |
|
April 12, 2033 |
|
0.12 |
|
|
2,020,733 |
|
|
| Disclosure of number and weighted average exercise prices of other equity instruments |
Set out below are summaries of the number of RSUs granted under the plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
Employees |
|
Eligible directors |
| As at January 1 |
|
— |
|
|
— |
|
| Granted during the period |
|
189,201 |
|
|
666,968 |
|
| Forfeited during the period |
|
— |
|
|
— |
|
| Vested and issued during the period |
|
— |
|
|
(666,968) |
|
| As at September 30 |
|
189,201
|
|
|
—
|
|
| Vested and exercisable at September 30 |
|
— |
|
|
— |
|
|